Literature DB >> 16220407

ConPas: a 3-D conformal parotid gland-sparing irradiation technique for bilateral neck treatment as an alternative to IMRT.

Ruud Wiggenraad1, Mirjam Mast, Jan van Santvoort, Marc Hoogendoorn, Henk Struikmans.   

Abstract

BACKGROUND AND
PURPOSE: Intensity-modulated radiotherapy (IMRT) is used in most reported techniques for bilateral neck irradiation that aim at parotid gland sparing. A relatively simple conformal parotid-sparing technique (ConPas) was developed that uses no beam-intensity modulation. The purpose of this paper is to demonstrate, in patients with larynx or hypopharynx carcinoma, that ConPas enables adequate coverage of the primary tumor and the bilateral neck nodes, while keeping the mean parotid dose (MPD) < 26 Gy. PATIENTS AND METHODS: Treatment plans using ConPas and the conventional technique (using one anteroposterior supraclavicular and two lateral beams) were computed for ten consecutive patients with T1-4 N0-1 larynx or hypopharynx carcinoma (not T1 glottic). A dose of 46 Gy was prescribed to the primary tumor and the bilateral neck nodes, planned either with the conventional technique or ConPas, followed by a boost up to 70 Gy with a simple two-field technique. The target coverage of both techniques was compared using the V(95), the percentage of the planning target volume (PTV) of the primary tumor and nodal regions receiving at least 95% of the prescribed elective dose. The MPDs and the normal-tissue complication probabilities (NTCPs) of the parotid glands were compared using either technique including the boost up to 70 Gy. Dosimetric verification of the technique has been carried out, using ionization chamber measurements and film dosimetry.
RESULTS: The mean V(95) was 85.2% and 91.2% (p = 0.08), the mean MPD 38.7 Gy and 25.4 Gy (p < 0.001), and the mean NTCP for the parotid glands 0.87 and 0.22 (p < 0.001) for the conventional technique and ConPas, respectively. The dosimetric verification shows a good agreement between dose calculation and measurement.
CONCLUSION: ConPas enables adequate target coverage and clinically relevant parotid sparing in bilateral neck irradiation without beam-intensity modulation.

Entities:  

Mesh:

Year:  2005        PMID: 16220407     DOI: 10.1007/s00066-005-1413-8

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  9 in total

1.  Investigations on parotid gland recovery after IMRT in head and neck tumor patients.

Authors:  Markus Stock; Wolfgang Dörr; Carmen Stromberger; Ulrike Mock; Susanne Koizar; Richard Pötter; Dietmar Georg
Journal:  Strahlenther Onkol       Date:  2010-11-30       Impact factor: 3.621

2.  Simultaneous integrated boost intensity-modulated radiotherapy (SIB‑IMRT) in nasopharyngeal cancer.

Authors:  Evangelia Peponi; Christoph Glanzmann; Guntram Kunz; Christoph Renner; Katja Tomuschat; Gabriela Studer
Journal:  Strahlenther Onkol       Date:  2010-02-22       Impact factor: 3.621

3.  The Expression of Checkpoint and DNA Repair Genes in Head and Neck Cancer as Possible Predictive Factors.

Authors:  Orsolya Rusz; Margit Pál; Éva Szilágyi; László Rovó; Zoltán Varga; Bernadett Tomisa; Gabriella Fábián; Levente Kovács; Olga Nagy; Petra Mózes; Zita Reisz; László Tiszlavicz; Péter Deák; Zsuzsanna Kahán
Journal:  Pathol Oncol Res       Date:  2016-07-13       Impact factor: 3.201

4.  Docetaxel, cisplatin and 5-fluorouracil induction chemotherapy followed by chemoradiotherapy or chemoradiotherapy alone in stage III-IV unresectable head and neck cancer: Results of a randomized phase II study.

Authors:  Zoltán Takácsi-Nagy; Erika Hitre; Éva Remenár; Ferenc Oberna; Csaba Polgár; Tibor Major; Mária Gödény; János Fodor; Miklós Kásler
Journal:  Strahlenther Onkol       Date:  2015-03-18       Impact factor: 3.621

5.  Changes in perfusion CT of advanced squamous cell carcinoma of the head and neck treated during the course of concomitant chemoradiotherapy.

Authors:  K Surlan-Popovic; S Bisdas; Z Rumboldt; T S Koh; P Strojan
Journal:  AJNR Am J Neuroradiol       Date:  2009-10-29       Impact factor: 3.825

6.  3D-conformal-intensity modulated radiotherapy with compensators for head and neck cancer: clinical results of normal tissue sparing.

Authors:  Thomas G Wendt; Nasrin Abbasi-Senger; Henning Salz; Ines Pinquart; Sven Koscielny; Susi-Marie Przetak; Tilo Wiezorek
Journal:  Radiat Oncol       Date:  2006-06-21       Impact factor: 3.481

7.  An opposed matched field IMRT technique for prostate cancer patients with bilateral prosthetic hips.

Authors:  Shahin Fattahi; Orest Z Ostapiak
Journal:  J Appl Clin Med Phys       Date:  2012-01-05       Impact factor: 2.102

8.  Dose-volume derived nomogram as a reliable predictor of radiotherapy-induced hypothyroidism in head and neck cancer patients.

Authors:  Marin Prpic; Ivan Kruljac; Davor Kust; Petar Suton; Neva Purgar; Lora Kirigin Bilos; Marin Gregov; Iva Mrcela; Maja Franceschi; Nikola Djakovic; Ana Frobe
Journal:  Radiol Oncol       Date:  2019-11-20       Impact factor: 2.991

9.  Comparative study of four advanced 3d-conformal radiation therapy treatment planning techniques for head and neck cancer.

Authors:  Mohamed Yassine Herrassi; Farida Bentayeb; Maria Rosa Malisan
Journal:  J Med Phys       Date:  2013-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.